Examples of this are the reported role of prolactin in the stimulation of angiogenesis [110] and of GH in the epithelial-to-mesenchymal transition seen in various tumor types [111], while antagonists of GH-releasing hormone receptors themselves have been shown to inhibit tumor growth and progression in different types of tumors [112,113,114]. This evidence concerns the gene PRL and neoplasm.